Status: current, Defined. Date: 31-Jul 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2004461000168111 | canakinumab 150 mg injection [1 x 150 mg vial] (&) inert substance diluent [1 vial], 1 pack (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2004471000168117 | canakinumab 150 mg injection [1 vial] (&) inert substance diluent [1 vial], 1 pack | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| canakinumab 150 mg injection [1 vial] (&) inert substance diluent [1 vial], 1 pack | Is a | canakinumab 150 mg injection, 1 vial | true | Inferred relationship | Some | ||
| canakinumab 150 mg injection [1 vial] (&) inert substance diluent [1 vial], 1 pack | has MPUU | inert substance diluent, vial | true | Inferred relationship | Some | 1 | |
| canakinumab 150 mg injection [1 vial] (&) inert substance diluent [1 vial], 1 pack | has MPUU | canakinumab 150 mg injection, vial | true | Inferred relationship | Some | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Ilaris (1 x 150 mg vial, 1 x inert diluent vial), 1 pack | Is a | True | canakinumab 150 mg injection [1 vial] (&) inert substance diluent [1 vial], 1 pack | Inferred relationship | Some |
Reference Sets
Medicinal product pack reference set
FHIR